| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Executive Senior Advisor
2 companies
Mallon Mark serves as a Chief Executive Officer at IRWD and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 5 sells. Those positions are worth an estimated $4.3M at current prices.
The biggest single holding is IRWD (~$4.3M) as Chief Executive Officer. The recent filings there lean toward selling, a net 61,865 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | NEO Neogenomics Inc | Chief Executive Officer | Buy | 17,000 | $30.63 | $520,710.00 | +30.5% | -43.0% | -63.4% | |
| Feb 26, 2021 | IRWD Ironwood Pharmaceuticals Inc | Chief Executive Officer | Sell | 30,675 | $9.11 | $279,449.25 | -6.1% | - | - | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | Chief Executive Officer | Sell | 23,206 | $10.35 | $240,182.10 | -4.4% | - | - | |
| Feb 24, 2020 | IRWD Ironwood Pharmaceuticals Inc | Chief Executive Officer | Sell | 7,984 | $11.63 | $92,853.54 | -2.6% | - | - |